BIOMAT Database Logo BIOMAT Database Logo

[Use of morphazinamide in therapy of tuberculosis in association with other antitubercular drugs and with intravenous, intrapleural and intraperitoneal administration]. 1965

B Mariani

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D011719 Pyrazines A heterocyclic aromatic organic compound with the chemical formula C4H4N2. Pyrazine
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular

Related Publications

B Mariani
[Results of therapy with morphazinamide administered orally in association with other antitubercular drugs].
September 1965, Minerva medica,
B Mariani
[Morphazinamide in association with other antimycobacterial drugs in the therapy of pulmonary tuberculosis].
September 1965, Minerva medica,
B Mariani
[THE USE OF MORPHAZINAMIDE IN ANTITUBERCULAR THERAPY].
January 1963, Giornale italiano di chemioterapia,
B Mariani
[THE USE OF MORPHAZINAMIDE IN ANTITUBERCULAR THERAPY].
January 1963, Giornale italiano di chemioterapia,
B Mariani
[THE USE OF MORPHAZINAMIDE IN ANTITUBERCULAR THERAPY].
January 1963, Giornale italiano di chemioterapia,
B Mariani
[Treatment of patients with renal tuberculosis by intravenous administration of antitubercular drugs].
January 1973, Problemy tuberkuleza,
B Mariani
[On the intrapleural and intrabronchial administration of morphazinamide administered alone and in association with dexamethasone 21-orthophosphate].
September 1965, Minerva medica,
B Mariani
[The hemogram and ESR in pulmonary tuberculosis during intravenous administration of the primary antitubercular drugs].
January 1971, Problemy tuberkuleza,
B Mariani
[Criteria of the application of morphazinamide in antitubercular therapy].
February 1967, Minerva medica,
B Mariani
[Therapy of pulmonary tuberculosis with morphazinamide alone and in combination with other antimycobacterial agents].
January 1966, Giornale italiano delle malattie del torace,
Copied contents to your clipboard!